The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
Authors:
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (2) , 454-461
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Current but not past hepatitis B virus infection is associated with a decreased risk of nonalcoholic fatty liver disease in the Chinese population: A case‐control study with propensity score analysisJournal of Viral Hepatitis, 2018
- New trends on obesity and NAFLD in AsiaJournal of Hepatology, 2017
- Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control studyJournal of Viral Hepatitis, 2017
- Healthy China 2030: A Vision for Health CareValue in Health Regional Issues, 2017
- Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2017
- Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta‐analysis of published studiesJournal of Gastroenterology and Hepatology, 2013
- Launch of the health-care reform plan in ChinaThe Lancet, 2009
- Urban-Biased Policies and Rising Income Inequality in ChinaAmerican Economic Review, 1999
- Genetic relationship of populations in ChinaProceedings of the National Academy of Sciences, 1998